title: Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
authors.affiliation: Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. Dy.Grace@mayo.edu
authors.forename: Grace K
authors.initials: GK
authors.lastname: Dy
authors.forename: James R
authors.initials: JR
authors.lastname: Jett
authors.forename: Francois J
authors.initials: FJ
authors.lastname: Geoffroy
authors.forename: Keith D
authors.initials: KD
authors.lastname: Krewer
authors.forename: Henry
authors.initials: H
authors.lastname: Tazelaar
authors.forename: Matthew
authors.initials: M
authors.lastname: Maurer
authors.forename: Kendrith
authors.initials: K
authors.lastname: Rowland
authors.forename: James
authors.initials: J
authors.lastname: Mailliard
authors.forename: James
authors.initials: J
authors.lastname: Krook
authors.forename: Shaker
authors.initials: S
authors.lastname: Dakhil
authors.forename: Leila
authors.initials: L
authors.lastname: Kutteh
authors.forename: John
authors.initials: J
authors.lastname: Kugler
authors.forename: Donald
authors.initials: D
authors.lastname: Wender
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000556:secondary; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality; D018450:Disease Progression; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced; D017239:Paclitaxel / Q000008:administration & dosage* / Q000009:adverse effects; D015996:Survival Rate; D019772:Topotecan / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D019772:Topotecan; D017239:Paclitaxel